| Literature DB >> 33923475 |
Marko Milojević1,2, Gregor Harih3, Boštjan Vihar1,4, Jernej Vajda1, Lidija Gradišnik1, Tanja Zidarič1, Karin Stana Kleinschek5, Uroš Maver1,2, Tina Maver2,6.
Abstract
Despite the extensive utilization of polysaccharide hydrogels in regenerative medicine, current fabrication methods fail to produce mechanically stable scaffolds using only hydrogels. The recently developed hybrid extrusion-based bioprinting process promises to resolve these current issues by facilitating the simultaneous printing of stiff thermoplastic polymers and softer hydrogels at different temperatures. Using layer-by-layer deposition, mechanically advantageous scaffolds can be produced by integrating the softer hydrogel matrix into a stiffer synthetic framework. This work demonstrates the fabrication of hybrid hydrogel-thermoplastic polymer scaffolds with tunable structural and chemical properties for applications in tissue engineering and regenerative medicine. Through an alternating deposition of polycaprolactone and alginate/carboxymethylcellulose gel strands, scaffolds with the desired architecture (e.g., filament thickness, pore size, macro-/microporosity), and rheological characteristics (e.g., swelling capacity, degradation rate, and wettability) were prepared. The hybrid fabrication approach allows the fine-tuning of wettability (approx. 50-75°), swelling (approx. 0-20× increased mass), degradability (approx. 2-30+ days), and mechanical strength (approx. 0.2-11 MPa) in the range between pure hydrogels and pure thermoplastic polymers, while providing a gradient of surface properties and good biocompatibility. The controlled degradability and permeability of the hydrogel component may also enable controlled drug delivery. Our work shows that the novel hybrid hydrogel-thermoplastic scaffolds with adjustable characteristics have immense potential for tissue engineering and can serve as templates for developing novel wound dressings.Entities:
Keywords: 3D printing; alginate; carboxymethyl cellulose; polycaprolactone; polysaccharide-based scaffolds; wound dressings
Year: 2021 PMID: 33923475 PMCID: PMC8073841 DOI: 10.3390/pharmaceutics13040564
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321
Figure 1Macropores of 3D printed scaffolds visualized under 2× and 4× magnification.
Measured filament thickness, pore dimensions, and calculated macroporosity of the 3D printed scaffolds.
| Parameters | AC | ACC | P | ACCP |
|---|---|---|---|---|
| Average filament thickness (mm) | 0.49 ± 0.04 | 0.38 ± 0.07 | 0.28 ± 0.08 | 0.33 ± 0.16 |
| Average pore width (mm) | 0.09 ± 0.07 | 0.19 ± 0.07 | 0.95 ± 0.02 | 0.17 ± 0.03 |
| Average pore length (mm) | 0.09 ± 0.04 | 0.20 ± 0.06 | 0.93 ± 0.01 | 0.50 ± 0.02 |
| Average pore | 0.007 ± 0.007 | 0.024 ± 0.012 | 0.768 ± 0.033 | 0.077 ± 0.014 |
| Macroporosity (%) | 1.53 | 9.73 | 56.78 | 15.72 |
Figure 2Scaffolds’ surface morphology and roughness parameters as measured by atomic force microscopy. The arrows indicate CaCl2 crystals on the surface of crosslinked alginate and carboxymethyl cellulose (ACC) scaffolds. P, pure polycaprolactone scaffold; ACCP, scaffold with alternating layers of ACC and PCL.
Figure 3SEM images of the 3D printed scaffolds.
Average water contact angle (CA) values with corresponding standard deviations for respective formulations.
| AC | ACC | P | ACCP |
|---|---|---|---|
| CA = 50.0 ± 3.8° | CA = 13.7 ± 1.6° | CA = 75.9 ± 0.9° | CA = 66.9 ± 2.2° |
Figure 4(a) Scaffold swelling test. (b) Scaffold degradation test.
Figure 5Compressive behavior of the (a) AC, (b) ACC, (c) P, and (d) ACCP 3D printed scaffolds. Distinct transition regions of the stress-strain curve are clearly marked for each specimen. The blue arrows indicate the yield points for individual materials.
Figure 6Tensile behavior of analyzed (a) ACC, (b) P, and (c) ACCP 3D printed specimens. Distinct transition regions of the stress-strain curve are clearly marked, whereas the arrows indicate either the yield or failure points, for individual specimens.
Figure 7Results of the MTT biocompatibility assay for keratinocytes (HaCaTs) (a,b) and human skin-derived fibroblasts (SFs) (c,d) obtained after 24-h and 48-h incubation periods. The asterisks indicate where the differences between the sample and the control were statistically significant (* p < 0.05).